The KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease (2012) recommends that ESAs not be used to maintain hemoglobin (Hb) concentrations above 11.5 g/dL (115 g/L) in adult patients with CKD. This evidence concerns the gene GSTM1 and chronic kidney disease.